Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 831.72K P/E - EPS this Y - Ern Qtrly Grth -
Income -563.15k Forward P/E - EPS next Y - 50D Avg Chg 33.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 36.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -33.00%
Recommedations - Quick Ratio 0.10 Shares Outstanding 87.10M 52W Low Chg 809.00%
Insider Own 19.28% ROA -10.45% Shares Float 71.04M Beta 0.70
Inst Own - ROE - Shares Shorted/Prior -/- Price 0.01
Gross Margin - Profit Margin - Avg. Volume 53,595 Target Price -
Oper. Margin - Earnings Date - Volume 17,011 Change 0.00%
About DIGIPATH INC

Digipath, Inc., together with its subsidiaries, developes cannabis and hemp. It provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company also operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. In addition, its laboratory screens medicinal and recreational cannabis for harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising of aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.